FORCE's XRAYS program, funded by the CDC, is a reliable resource for young breast cancer survivors and high-risk women to navigate through breast cancer research related news and information.
FORCE developed our eXamining the Relevance of Articles for Young Survivors (XRAYS) program to empower young breast cancer survivors and high-risk women by providing tools for evaluating reports of new breast cancer-related research. Funded by the CDC, XRAYS will provide reviews and ratings of news media articles on breast cancer research to help young breast cancer survivors better understand research that is relevant to them. Learn more about the XRAYS program
Some breast cancer patients are given
neoadjuvant (before surgery) chemotherapy. However, some recent studies have raised concerns that neoadjuvant treatment might actually trigger cancer spread in certain situations. In the current study, researchers used mouse models and human breast cancers to explore this possibility. (10/10/17)
Barbara Jacoby's Huffington Post piece, "How do breast cancer and metastatic breast cancer differ?" emphasizes the need for more treatment options for patients with advanced breast cancer.